Stakeholder perspectives on treatments for neurocognitive and behavioral concerns in RASopathies / closed
University of Minnesota | 2023
Download ArticleUniversity of Minnesota | 2023
Download Article
Stanford University, in collaboration with Johns Hopkins University and The University of California San Francisco (UCSF)
| 2023
By Kavita Sarin, MD, PhD and Carlos Romo, MD
NFlection Therapeutics | 2023
Phase two trial is done. A phase three trial may open soon. Latest update.
View Article
Ann & Robert H. Luries Childrens Hospital of Chicago
| 2023
By Carlos Prada, MD
Recruiting NF1 individuals with known Plexiform Neurofibromas
View Article
Massachusetts General Hospital/Harvard
| 2022
By Julie Brewer
University of Wisconsin and Minnesota
| 2022
By Bonnie Klein-Tasman, PhD
University of Wisconsin-Milwaukee
| 2021
By Bonnie Klein-Tasman, PhD
University of Wisconsin-Milwaukee
| 2021
By Bonnie Klein-Tasman, PhD
© 2025 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.